Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]

Critical Care

Volumn 10, Issue 3, 2006, Pages

  Christ Crain, Mirjam ^a   Morgenthaler, Nils G ^b   Stolz, Daiana ^a   Müller, Christian ^a   Bingisser, Roland ^a   Harbarth, Stephan ^c   Tamm, Michael ^a   Struck, Joachim ^b   Bergmann, Andreas ^b   Müller, Beat ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b THERMO FISHER SCIENTIFIC   (Germany)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROADRENOMEDULLIN; PROCALCITONIN; ADRENOMEDULLIN; PROTEIN; PROTEIN PRECURSOR;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PNEUMONIA SEVERITY INDEX; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SURVIVAL; BLOOD; COMMUNITY-ACQUIRED INFECTIONS; COMPARATIVE STUDY; FOLLOW UP; MIDDLE AGED; PNEUMONIA; PREDICTIVE VALUE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY;

ADRENOMEDULLIN; AGED; AGED, 80 AND OVER; BIOMARKERS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; PROTEINS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34248330207     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc4955     Document Type: Article

References (40)

1. Hinson JP Kapas S Smith DM Adrenomedullin, a multifunctional regulatory peptide Endocr Rev 2000 21 138-167 10.1210/er.21.2.138 10782362
2. Eto T A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides Peptides 2001 22 1693-1711 10.1016/ S0196-9781(01)00513-7 11754955
3. Kitamura K Sakata J Kangawa K Kojima M Matsuo H Eto T Cloning and characterization of cDNA encoding a precursor for human adrenomedullin Biochem Biophys Res Commun 1993 194 720-725 10.1006/bbrc.1993.1881 7688224
4. Linscheid P Seboek D Zulewski H Keller U Muller B Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue Endocrinology 2005 146 2699-2708 10.1210/en.2004-1424 15761041
5. Pio R Martinez A Unsworth EJ Kowalak JA Bengoechea JA Zipfel PF Elsasser TH Cuttitta F Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners J Biol Chem 2001 276 12292-12300 10.1074/jbc.M007822200 11116141
6. Marutsuka K Nawa Y Asada Y Hara S Kitamura K Eto T Sumiyoshi A Adrenomedullin and proadrenomudullin N-terminal 20 peptide (PAMP) are present in human colonic epithelia and exert an antimicrobial effect Exp Physiol 2001 86 543-545 10.1113/eph8602250 11571480
7. Martinez A Pio R Zipfel PF Cuttitta F Mapping of the adrenomedullin-binding domains in human complement factor H Hypertens Res 2003 26 Suppl S55-59 10.1291/hypres.26.S55 12630812
8. Hirata Y Mitaka C Sato K Nagura T Tsunoda Y Amaha K Marumo F Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis J Clin Endocrinol Metab 1996 81 1449-1453 10.1210/jc.81.4.1449 8636349
9. Jougasaki M Burnett JC Jr Adrenomedullin: Potential in physiology and pathophysiology Life Sci 2000 66 855-872 10.1016/S0024-3205(99)00358-6 10714887
10. Kato J Tsuruda T Kitamura K Eto T Adrenomedullin: A possible autocrine or paracrine hormone in the cardiac ventricles Hypertens Res 2003 26 Suppl S113-119 10.1291/hypres.26.S113 12630821
11. Struck J Tao C Morgenthaler NG Bergmann A Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients Peptides 2004 25 1369-1372 10.1016/j.peptides.2004.06.019 15350706
12. Christ-Crain M Morgenthaler NG Struck J Harbarth S Bergmann A Muller B Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: An observational study Crit Care 2005 9 R816-824 1414007 16356231 10.1186/ cc3885
13. Mortensen EM Coley CM Singer DE Marrie TJ Obrosky DS Kapoor WN Fine MJ Causes of death for patients with community-acquired pneumonia: Results from the Pneumonia Patient Outcomes Research Team cohort study Arch Intern Med 2002 162 1059-1064 10.1001/archinte.162.9.1059 11996618
14. Niederman MS Mandell LA Anzueto A Bass JB Broughton WA Campbell GD Dean N File T Fine MJ Gross PA Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention Am J Respir Crit Care Med 2001 163 1730-1754 11401897
15. Bartlett JG Dowell SF Mandell LA File TM Jr Musher DM Fine MJ Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America Clin Infect Dis 2000 31 347-382 10.1086/313954 10987697
16. Mandell LA Marrie TJ Grossman RF Chow AW Hyland RH Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group Clin Infect Dis 2000 31 383-421 10.1086/313959 10987698
17. Fine MJ Auble TE Yealy DM Hanusa BH Weissfeld LA Singer DE Coley CM Marrie TJ Kapoor WN A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 1997 336 243-250 10.1056/ NEJM199701233360402 8995086
18. Lim WS van der Eerden MM Laing R Boersma WG Karalus N Town GI Lewis SA Macfarlane JT Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study Thorax 2003 58 377-382 10.1136/thorax.58.5.377 12728155
19. Almirall J Bolibar I Toran P Pera G Boquet X Balanzo X Sauca G Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Chest 2004 125 1335-1342 10.1378/chest.125.4.1335 15078743
20. Masia M Gutierrez F Shum C Padilla S Navarro JC Flores E Hernandez I Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index Chest 2005 128 2223-2229 10.1378/chest.128.4.2223 16236878
21. Querol-Ribelles JM Tenias JM Grau E Querol-Borras JM Climent JL Gomez E Martinez I Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia Chest 2004 126 1087-1092 10.1378/ chest.126.4.1087 15486368
22. Christ-Crain M Stolz D Bingisser R Muller C Miedinger D Huber PR Zimmerli W Harbarth S Tamm M Muller B Procalcitonin-guidance of antibiotic therapy in community-acquired pneumonia - a randomized trial Am J Respir Crit Care Med 2006 16603606
23. Christ-Crain M Jaccard-Stolz D Bingisser R Gencay MM Huber PR Tamm M Muller B Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial Lancet 2004 363 600-607 10.1016/ S0140-6736(04)15591-8 14987884
24. Morgenthaler NG Struck J Alonso C Bergmann A Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay Clin Chem 2005 51 1823-1829 10.1373/clinchem.2005.051110 16099941
25. Harbarth S Holeckova K Froidevaux C Pittet D Ricou B Grau GE Vadas L Pugin J Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis Am J Respir Crit Care Med 2001 164 396-402 11500339
26. Aronsky D Dean NC How should we make the admission decision in community-acquired pneumonia? Med Clin North Am 2001 85 1397-1411 10.1016/S0025-7125(05)70387-4 11680109
27. Wipf JE Lipsky BA Hirschmann JV Boyko EJ Takasugi J Peugeot RL Davis CL Diagnosing pneumonia by physical examination: Relevant or relic? Arch Intern Med 1999 159 1082-1087 10.1001/archinte.159.10.1082 10335685
28. McIvor RA Plasma d-dimer for outcome assessment in patients with CAP: not a replacement for PSI Chest 2004 126 1015-1016 10.1378/ chest.126.4.1015 15486354
29. Farr BM Sloman AJ Fisch MJ Predicting death in patients hospitalized for community-acquired pneumonia Ann Intern Med 1991 115 428-436 1872491
30. Fine MJ Singer DE Hanusa BH Lave JR Kapoor WN Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database Am J Med 1993 94 153-159 10.1016/0002-9343(93)90177-Q 8430711
31. Garcia-Ordonez MA Garcia-Jimenez JM Paez F Alvarez F Poyato B Franquelo M Colmenero JD Juarez C Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired pneumonia Eur J Clin Microbiol Infect Dis 2001 20 14-19 10.1007/s100960000413 11245317
32. Aronsky D Haug PJ Assessing the quality of clinical data in a computer-based record for calculating the pneumonia severity index J Am Med Inform Assoc 2000 7 55-65 61455 10641963
33. Niederman MS Craven DE Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 2005 171 388-416 10.1164/ rccm.200405-644ST 15699079
34. Kolsuz M Erginel S Alatas O Alatas F Metintas M Ucgun I Harmanci E Colak O Acute phase reactants and cytokine levels in unilateral community-acquired pneumonia Respiration 2003 70 615-622 10.1159/ 000075208 14732793
35. Luna CM C-reactive protein in pneumonia: Let me try again Chest 2004 125 1192-1195 10.1378/chest.125.4.1192 15078723
36. Christ-Crain M Muller B Procalcitonin in bacterial infections - hype, hope, more or less? Swiss Med Wkly 2005 135 451-460 16208582
37. Becker KL Nylen ES White JC Muller B Snider RH Jr Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: A journey from calcitonin back to its precursors J Clin Endocrinol Metab 2004 89 1512-1525 10.1210/ jc.2002-021444 15070906
38. Shoji H Minamino N Kangawa K Matsuo H Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat Biochem Biophys Res Commun 1995 215 531-537 10.1006/bbrc.1995.2497 7487988
39. Linscheid P Seboek D Zulewski H Keller U Muller B Autocrine/paracrine role of inflammation-mediated Calcitonin Gene-Related Peptide and Adrenomedullin expression in human adipose tissue Endocrinology 2005 146 6 2699-708 10.1210/en.2004-1424 15761041
40. Nishikimi T Kitamura K Saito Y Shimada K Ishimitsu T Takamiya M Kangawa K Matsuo H Eto T Omae T Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects Hypertension 1994 24 600-604 7960020